Eli Lilly (LLY:NYSE) has signed a research collaboration with Hong Kong-listed Metis TechBio (7666. HK:HKSE) that Reuters reported on Monday, October 19, is worth up to $1.
The company continues to dominate the weight loss market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results